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Abstract
Background: Foot involvement occurs early in rheumatoid arthritis but the extent to which this
impacts on the structure and function leading to impairment and foot related disability is unknown.
The purpose of this study was to compare clinical disease activity, impairment, disability, and foot
function in normal and early rheumatoid arthritis (RA) feet using standardised clinical measures and
3D gait analysis.
Methods: Twelve RA patients with disease duration ≤2 years and 12 able-bodied adults matched
for age and sex underwent 3D gait analysis to measure foot function. Disease impact was measured
using the Leeds Foot impact Scale (LFIS) along with standard clinical measures of disease activity,
pain and foot deformity. For this small sample, the mean differences between the groups and
associated confidence intervals were calculated using the t distribution
Results: Moderate-to-high foot impairment and related disability were detected amongst the RA
patients. In comparison with age- and sex-matched controls, the patients with early RA walked
slower (1.05 m/s Vs 1.30 m/s) and had a longer double-support phase (19.3% Vs 15.8%). In terminal
stance, the heel rise angle was reduced in the patients in comparison with normal (-78.9° Vs -85.7°).
Medial arch height was lower and peak eversion in stance greater in the RA patients. The peak ankle
plantarflexion power profile was lower in the patients in comparison with the controls (3.4 W/kg
Vs 4.6 W/kg). Pressure analysis indicated that the RA patients had a reduced lesser toe contact area
(7.6 cm2 Vs 8.1 cm2), elevated peak forefoot pressure (672 kPa Vs 553 kPa) and a larger mid-foot
contact area (24.6 cm2 Vs 19.4 cm2).
Conclusion: Analysis detected small but clinically important changes in foot function in a small
cohort of RA patients with disease duration <2 years. These were accompanied by active joint
disease and impairment and disability.
Background
Small joint inflammation in the hands and feet are the
hallmark of early rheumatoid arthritis (RA). Clinical stud-
ies suggest foot pain may be problematic in about one-
third of patients in early disease with more frequent
involvement of the metatarsophalangeal (MTP) joints
(34%) in comparison with the midtarsal (4%) and ankle
(20%) regions [1]. Radiographically, the joints of the feet
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show damage more often, and earlier than the joints of
the hand [2]. Furthermore, in patients with disease dura-
tion of <12 months, edema, synovitis and erosion can be
detected by magnetic resonance imaging (MRI) at the
MTP joints in patients whose hands are normal [3]. Ultra-
sonography has also revealed MTP joint effusion, flexor
tenosynovitis and plantar bursa in early disease [4]. By
contrast, tarsal/ankle joint pathology occurs later in the
disease with joint space narrowing and erosion in the
ankle found in less than 2% of patients within the first 3
years [5,6].
Whilst imaging enables detection of joint and soft-tissue
pathology, clinical signs of foot disease are often more
subtle in early RA and data are lacking. In the forefoot,
abnormal MTP joint alignment, subluxation and stiffness
were found in 25% of patients within 3 years of disease
onset [7]. In the hindfoot, <10% of cases had moderate to
severe deformity by 5 years, although gait analysis can
enable detection of collapsing pes valgus within 3 years
[7,8]. Normal foot joint motion is necessary to allow the
body to progress over the supporting foot during stance.
This complex structure must facilitate weight acceptance
and transfer, contribute shock absorption and stability
and distribute pressure evenly on the plantar surface. The
consequences of persistent synovitis in terms of disrupt-
ing these functions are well documented for established
RA [8-13] but the association between joint damage in the
feet, impairment and function has not been evaluated in
early disease. Nevertheless, strong recommendations have
been made for careful attention to foot problems in early
disease with an emphasis towards correcting underlying
biomechanical faults, chiefly through the use of orthotic
devices [14,15].
We require a better understanding of the impact of RA in
the foot and we have recently developed metrics that accu-
rately and reproducibly measure impairment and disabil-
ity [16]. Moreover, three-dimensional (3D) gait analysis
permits high-definition measurement of foot function
and we have successfully studied this in patients with
well-established disease [8,12,13]. Therefore, the aim of
this study is to compare clinical disease activity, impair-
ment, disability, and foot function in normal and early
rheumatoid arthritis (RA) feet using standardised clinical
measures and 3D gait analysis.
Methods
Patients
Twelve patients with a history of rheumatoid arthritis ≤2
years duration (from symptom onset) were consecutively
recruited from the Early Arthritis Clinic at the Leeds Gen-
eral Infirmary, UK. All patients had foot problems merit-
ing referral to the rheumatology specialist podiatrist.
Twelve community dwelling adults with no history of
inflammatory arthritis or musculoskeletal disease involv-
ing the lower limb and foot were recruited for compari-
son. This study received ethical approval from Harrogate
Local Research Ethics Committee (REC reference number
04/03/03).
Clinical data
The age, sex, disease duration, disease activity score (using
28 joint counts), erosive state (Larsen score ≥2) of MTP
joints, body height and mass and current disease modify-
ing anti-rheumatic drugs (DMARD) were recorded for
each patient. Using standardised techniques, a single cli-
nician (JW) recorded swollen (SJC) and tender (TJC) joint
scores in the foot at the ankle, subtalar, calcaneocuboid,
talonavicular, metatarsophalangeal, interphalangeal joint
of the hallux and proximal interphalangeal joints of the
lesser toes (range 0–14). The number of patient reported
painful (PJC) joint sites as directly indicated on the foot or
on a foot map if the feet could not be reached was also
recorded (range (0–14). Disease impact was measured
using the Leeds Foot Impact Scale [16]. This self com-
pleted questionnaire comprises two subscales for impair-
ment/footwear (LFIFIF) and activity limitation/
participation restriction (LFISAP). The former contains 21
items related to foot pain and joint stiffness as well as
footwear related impairments and the latter contains 30
items related to activity limitation and participation
restriction [16]. Fore- and rearfoot deformities were quan-
tified using the Structural Index (SI) score [9]. This scale
summates hallux valgus, 5th MTP exostosis, claw/hammer
toe and MTP subluxation deformities for the forefoot
(range 0–12) and calcaneus valgus/varus, ankle range of
motion and pes planus/cavus deformities for the rearfoot
(range 0–7). The varus/valgus alignment of the heel
(RSFP) was measured using a standard hand-held goni-
ometer [13].
Gait analysis
A six-camera 60 Hz video-based motion analysis system
(Falcon System, Motion Analysis Corporation, Santa
Rosa, CA, USA) was used to track the motion of 22 spher-
ical reflective targets (10 mm diameter) placed on the
shank and foot [13]. Visual3D software (C-motion, Inc.,
Rockville, MD, USA) was used to build segmented foot
models based on the coordinates of the markers placed
over specific anatomical landmarks during static calibra-
tion. Marker placement and segment models were based
on those described by Carson et al (2001) [17]. The model
comprised the shank, rearfoot, forefoot, and hallux seg-
ments. To permit calculation of ankle joint moments and
power a single foot segment was also created. A single
marker was also located over the tuberosity of the navicu-
lar to measure arch height during the foot flat period of
stance [13]. Ground reaction forces and the distribution
of pressure on the plantar surface were simultaneouslyBMC Musculoskeletal Disorders 2006, 7:102 http://www.biomedcentral.com/1471-2474/7/102
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measured using dual-mounted force (Bertec Corporation,
Columbus, OH, USA) and pressure (EMED-ST, Novel
GmbH, Munich, Germany) plates. An instrumented walk-
way (GAITrite, CIR systems, Clifton, NJ, USA) was used to
capture spatiotemporal gait parameters.
From an average of five walking trials a pre-determined
core set of foot biomechanical variables was extracted
from the gait measurements [8-13]. These included walk-
ing speed and double-support as objective measures of
global function [9,12,13]. Movement of the single foot
segment relative to the floor was used to extract initial foot
contact and the terminal stance heel rise angles in the sag-
ittal plane (+ dorsiflexion/- plantarflexion). From the
plantar pressure analysis, we derived the time as a % of
stance when the centre-of-pressure reached 50% of foot
length. These three measurements were used to describe
the rocker function of the foot [10,11,13]. Arch height was
defined as the lowest navicular height during the foot flat
period of stance derived from the vertical (z) coordinate
of the navicular motion tracking marker. From the move-
ment of the rearfoot relative to the shank in the frontal
plane, peak eversion motion was derived during stance (+
inversion/- eversion). These two variables provided meas-
urements for planovalgus deformity for the mid- and rear-
foot [8,12,13]. Kinetic variables describe the forces
responsible for producing movement and peak vertical
(+) ground reaction forces acting perpendicular to the
plantar foot surface during the loading response and ter-
minal stance were selected for analysis [10]. The dorsi/
plantar flexion muscular moment and power acting about
the ankle joint in the sagittal were also estimated [11]. For
the recorded plantar pressure distributions, an automated
software routine was used to define the forefoot (tarso-
metatarsal to distal metatarsal head area) and toe (com-
bined hallux and lesser toes) regions of the foot. We
derived the peak pressure for the forefoot and the contact
area for the toes regions as metrics to capture functional
changes associated with MTP deformity which is highly
prevalent in RA. Similarly, contact area in the mid-foot
(defined as the region from the distal plantar heel to the
tarso-metatarsal junction) was measured to assess col-
lapse of the medial longitudinal arch which is associated
with pes planovalgus [12].
Statistical analyses
The clinical and biomechanical variables are summarised
as mean (SD) or median (range). The small sample size
did not permit formal hypothesis testing therefore to
compare differences between the study groups, the mean
differences and associated confidence intervals were cal-
culated using the t distribution. A group ensemble aver-
age, displayed as a time series graph, was prepared for 4
selected biomechanical variables.
Results
Demographic and clinical characteristics
Twelve female RA patients with a median age of 46 years
(range 27–63) were studied (Table 1). Able-bodied con-
trol subjects were closely matched by age and sex. Of the
12 patients studied; 3 had erosive MTP joints; 10 were
treated with DMARD agents; 3 had high disease (DAS28
>5.1); 5 medium disease (DAS28 >3.2 ≤5.1); and 4 low
disease (DAS28 ≤3.2).
Foot impairments
The 3 patients with high disease activity had moderate-to-
high (LFISIF >7 point, LFISAP >10 points) levels of foot
impairment and disability on the LFIS subscales com-
bined with a high number of swollen, tender and painful
foot joints and only mild deformity (SI ≤ 3) in the fore-
foot (Table 1). One patient had a passively correctable
v a r u s  h e e l  d e f o r m i t y  o n  w e i g h t - b e a r i n g  ( p a t i e n t  2 ,  6 °
varus).
Moderate levels of foot impairment and related disability
were observed in the 5 patients with moderate disease
activity. All 5 had tender joints with most frequent
involvement at the MTP joints. Three from 5 patients had
self reported painful foot joints. 2/5 patients had swollen
foot joints. Four from five cases had valgus heel deformity
in excess of the median for the able-bodied control sub-
jects (range 4 to 9° valgus) with three cases showing early
signs of pes planovalgus on the SI score. Two patients had
marked deformity in the forefoot.
In the series of 4 patients with low disease activity there
was a mixed pattern of clinical disease activity, foot related
impairment and disability and deformity. These patients
exhibited; low levels of clinical synovitis; residual impair-
ment characterised by low-moderate LFIS subscale scores;
and deformity notably of the rearfoot with 3 cases show-
ing planovalgus and 1 case varus foot deformity.
Gait analysis
Several differences were exhibited by the early RA patients
in comparison with the able-bodied control subjects. A
reduction in walking speed and an increase in double-
support time indicated marked changes in global function
(Table 2). The initial foot-to-floor contact angle was
unchanged but during terminal stance the heel rise was
reduced on average by 6.7° (Table 1, Figure 1A). Kinemat-
ics of the mid- and rearfoot showed an overall trend
towards a slight reduction in medial longitudinal arch
height accompanied by an exaggerated everted heel pos-
ture throughout the stance phase (Figure 1B). Both meas-
urements were highly variable as two patients (patients 2
and 10) had varus heel deformity, thereby causing the
medial longitudinal arch to rise and the rearfoot to invert.BMC Musculoskeletal Disorders 2006, 7:102 http://www.biomedcentral.com/1471-2474/7/102
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The peak vertical ground reaction force was slightly
blunted during the loading response and normal during
terminal stance (Figure 1C). The peak plantarflexion net
muscular moment was unchanged but there was a trend
towards a reduction in the peak ankle joint power (mean
difference 1.3 W/kg). The centre-of-pressure at 50% of
foot length occurred at the same time (~44% of stance).
Plantar pressure distribution showed a slight reduction in
lesser toe contact area; an increase in midfoot contact area;
and an average increase in the peak forefoot pressure of
22%.
Discussion
There has been an increasing use of gait analysis as an
objective measure of foot function in RA [8-13]. This
prompted us to investigate the relationship between
impairment, clinical disease activity and function in a
group of RA patients with early disease. Our study showed
moderate-to-high levels of disease impact in the foot asso-
Table 2: Gait characteristics in patients with early rheumatoid arthritis and age and sex matched able-bodied adults
Parameter Variable Able-bodied Adults 
(n = 12)
Early RA Patients 
(n = 12)
Mean Difference 95%CI Difference
Spatiotemporal Walking speed (m/s) 1.30 (0.17) 1.05 (0.20) -0.24 (-0.41, -0.08)
Double-support (%GC) 15.8 (3.4) 19.3 (4.7) 3.5 (0, 7.0)
Kinematics Initial foot contact angle (deg) 13.8 (2.4) 14.2 (4.5) -0.4 (-3.5, 2.7)
Terminal stance heel rise (deg) -85.7 (5.4) -78.9 (9.6) 6.7 (0.1, 13.5)
Minimum arch height (mm) 31 (5) 29 (7) -2 (-8, 3)
Peak eversion (deg) -4.4 (3.4) -5.5 (9.8) -1.1 (-7.5, 5.4)
Kinetics/Moments/Power Peak force loading response (BW) 1.11 (0.12) 1.05 (0.12) -0.07 (-0.17, 0.04)
Peak force terminal stance (BW) 1.12 (0.62) 1.12 (0.61) 0 (-0.05, 0.05)
Peak plantarflexion moment (Nm/kg) -1.6 (0.1) -1.5 (0.1) 0 (-0.1, 0.1)
Peak ankle joint power (W/kg) 4.6 (1.6) 3.4 (1.0) -1.3 (-2.4, 0.2)
Foot pressure CoP at 50% foot length (% stance) 44.2 (5.0) 44.3 (10.8) 0.1 (-7.2, 7.4)
Lesser toes contact area (cm-2) 8.1 (1.9) 7.6 (3.1) -0.5 (-2.7, 1.7)
Midfoot contact area (cm-2) 19.4 (6.5) 24.6 (7.2) 5.3 (-0.6, 11.1)
Forefoot peak pressure (kPa) 553 (193) 672 (255) 119 (-73, 311)
CI = confidence interval; BW = body weight (vertical ground reaction force normalised to body weight)
Table 1: Demographic, clinical and foot impairment/disability scores for 12 RA patients and normal reference values for 12 age and sex 
matched able-bodied adults
Patient/Age/
Foot
DMARD BMI (kg/m2) DAS28 
(0–10)
Erosive 
Disease
LFISIF 
(0–21)
LFISAP 
(0–30)
SJC 
(0–14)
TJC 
(0–14)
PJC 
(0–14)
SIFF 
(0–12)
SIRF 
(0–7)
RSFP 
(deg)
1/43/L MTX 30.5 7.3 - 14 19 14 14 4 1 0 -5 valgus
2/48/R - 26.3 6.2 - 11 12 11 5 3 0 0 6 varus
3/36/R SSZ 19.5 5.5 - 17 23 8 12 5 3 0 -4 valgus
4/55/L MTX 27.4 5.0 + 6 8 0 2 0 2 1 -9 valgus
5/50/R - 27.0 4.1 - 11 14 9 9 2 0 0 -4 valgus
6/27/R MTX 25.1 4.1 Missing 9 10 1 9 2 0 1 -8 valgus
7/44/L MTX, SSZ, 
HCQ
3 5 . 1 3 . 7 - 1 1 6 01050- 2  v a l g u s
8/32/R TNFα, 
MTX
21.9 3.4 - 12 22 0 7 4 9 2 -7 valgus
9/58/R MTX 25.0 2.7 - 10 3 1 10 1 0 0 -6 valgus
10/60/L MTX 38.9 2.5 + 10 15 0 1 0 6 2 7 varus
11/43/R SSZ 28.5 2.3 + 7 5 0 3 1 10 1 -8 valgus
12/63/L MTX, 
HCQ
3 2 . 0 2 . 3 - 1 0 7 00022- 9  v a l g u s
Median 46 - 27.2 3.9 11 11 1 6 2 2 1 -6 valgus
Range 27–63 - 19.5–35.1 2.3–7.3 6–17 3–23 0–14 0–14 0–5 0–10 0–2 -9 valgus-7 
varus
Reference values (n = 12)
Median 47 - 23.7 - - 1 0 0 0 0 1 0 -3 valgus
Range 27–64 - 19.1–31.8 - - 0–4 0–2 0–2 0–1 0 0–2 0–2 -8 valgus-1 
varus
DMARD = disease-modifying antirheumatic drug; MTX = methotrexate; SSZ = sulphasalazine; HCQ = hydroxychloroquine; TNFα = tumour 
necrosing factor α blockade; BMI = body mass index; DAS28 = disease activity score using 28 joint counts; LFISIF = Leeds Foot Impact Scale-
Impairment/Footwear subscale score 9 range 0–21); LFISAP = Leeds Foot Impact Scale-Activity Limitation/Participation Restriction subscale score 
(range 0–30); SJC = swollen joint count (range 0–14); TJC = tender joint count (range 0–14); PJC = painful joint count (range 0–14); SIFF = structural 
index for forefoot; SIRF = structural index for rearfoot. RSFP = relaxed standing foot posture.BMC Musculoskeletal Disorders 2006, 7:102 http://www.biomedcentral.com/1471-2474/7/102
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ciated with varying levels of clinical disease activity, pain,
deformity and altered function. The LFIS is a new vali-
dated measure of disease impact in the foot developed by
our own group [16]. Moderate to high levels of impair-
ment and foot related disability were observed in these
early patients. Indeed, the median scores were similar to
those currently observed amongst our own clinic patients
with established disease of >5 years. Therefore, LFIS like
HAQ (a disability metric which predicts poor outcome
when high at disease onset) may be an important predic-
tive measure of future localised disease impact [16,18].
Despite DMARD treatment in 10/12 patients, all of the
early patients were suffering foot pain which may have
been related to inflammation or impairment or both.
Inflammatory processes may be the predominant deter-
minant of disability in early RA, with structural abnormal-
ities leading to functional impairment in well established
disease. In the foot, for example, synovitis is thought to
reflect underlying systemic disease activity [19] whilst
pain and disability correlate strongly with patients self
perception of foot pain but not disease duration, joint
damage or systemic drug treatment [20]. Furthermore,
impairment of gait and mobility are associated with well
recognised patterns of pain and foot deformity [8-13].
These problems reported in cohorts of patients with well-
established RA are not very different from those reported
in this study. We were able to detect functional limitation
in gait in patients with <2 years disease duration charac-
terised by slow walking speed and increased double-sup-
Selected gait parameters normalised for 100% stance (each graph is individually scaled and the gray band represents the mean  ± 1 SD for the able-bodied adults and the solid line is the mean ± 1 SD error bars for the RA patients Figure 1
Selected gait parameters normalised for 100% stance (each graph is individually scaled and the gray band represents the mean 
± 1 SD for the able-bodied adults and the solid line is the mean ± 1 SD error bars for the RA patients. A – Initial foot-to-floor 
and terminal stance heel rise angles during stance, measured as the angle of the plantar surface of the foot to the horizontal. 
Positive angles decreasing to zero indicate increasing foot-to-floor contact, zero indicates foot flat, and increasing negative 
angles indicate progressive heel rise; B – frontal plane motion of the rearfoot in the shank coordinate system during stance 
phase (+ inversion/- eversion); C – ground reaction forces normalised to body mass acting perpendicular to the plantar aspect 
of the foot; D – sagittal plane ankle joint power during stance).
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port and this may suggest early adaptation to underlying
systemic and local disease activity and impairments [9-
13].
Gait analysis has improved out understanding of foot
function in established RA but has not been reported in
early disease. Typical forefoot deformities such as hallux
valgus, MTP joint subluxation and hammer toe deformi-
ties (component scores of the SI) were detected in 75% of
the early RA patients and 50% of the control subjects.
Although not staged by severity, deformity was worse in
the RA cases resulting in a reduced weightbearing contact
area for the toes and elevated peak pressures at the plantar
MTP joints. Furthermore, plantar pressures are higher at
MTP joint which are eroded and of three patients with ero-
sive changes, two had peak values outside normal limits
(>2 SD above normal mean limit) [21]. If untreated, these
stresses may be associated with persistent or worsening
symptoms and the development of secondary pressure
lesions such as callus, bursa and ulceration [22,23]. How-
ever, some patients can off-load these painful sites by
avoiding weight transfer to the forefoot. O'Connell et al
(1998) reported disruption to the rocker function of the
foot characterised by; delay of transfer of centre-of-pres-
sure to the forefoot; delay of heel-rise and reduced peak
vertical force; and net ankle plantar flexor muscle moment
in terminal stance [11]. These compensations were obvi-
ous and marked in some cases but not others and overall
no differences were detected other than for a delayed heel-
rise in the early cases. Further work is required to deter-
mine more fully which of these metrics are the most sen-
sitive to detect early changes. A second off-loading strategy
for painful forefoot is to move the foot into a varus pos-
ture, especially if the medial MTP joints are involved, and
this was detected in 2 of our cases. Fixed varus deformities
of the rearfoot are reportedly present in about 2% of RA
patients [24]. In our experience these are difficult to man-
age clinically. The long term functional consequences of
this impairment are unclear.
Inflammatory synovitis and dysfunction of the peritalar
joints and the tibialis posterior muscle-tendon unit are
postulated mechanisms leading to instability of the subta-
lar and mid-tarsal joints [25]. This is clinically recognisa-
ble as pes planovalgus which has a reported prevalence of
between 46–64% in RA [8,12,26,27]. The natural history
of this progressive deformity is poorly understood but
data from the present study suggests it may occur early
and progress rapidly. In this study, clinical examination
was used to successfully identify synovitis in and around
the peri-talar joints. The consequence for these patients
may be the progressive development of pes planovalgus.
Indeed, 9/12 patients on standing had an exaggerated val-
gus heel posture above the normal values. Furthermore,
we have previously described collapse of the medial lon-
gitudinal arch accompanied by an increase in the maxi-
mum rearfoot eversion reached during stance when
walking [8,12,13]. These two motion deficits were clearly
identified in this patient cohort, albeit two cases with
moderately severe varus heel deformity appreciably skew
the data. Finally, collapse of the medial longitudinal arch
creates a larger midfoot weightbearing surface and in the
early RA cases this was 21% greater than healthy controls.
In the planovalgus foot, the gastrocnemius-solues com-
plex shows evidence of increased activity in an attempt to
minimise the valgus deformity [28]. The third rocker func-
tion of the foot occurs about the forefoot as the heel rises
in late stance and this is controlled by concentric contrac-
tion of the ankle plantarflexors. However, under manual
muscle strength tests, the gastocnemius-soleus muscle
group is usually weak in RA patients. The associated func-
tional consequence may be reduced ankle joint power
during terminal stance and this was detected for the RA
patients in this study [11,28]. Since the net muscular
moment was normal, the reduced ankle power must be
caused by a reduction in the angular velocity at the joint.
Factors contributing to reduce ankle joint angular velocity
such as walking speed and reduced range of motion were
detected amongst the patients but other gait-limiting fac-
tors and adaptations to impairments such as pain and
deformity could not be fully accounted for. Finally, the
blunting of the first peak of the vertical ground reaction
force, suggests that some patients may have been cautious
in loading the foot during initial foot contact phase, per-
haps in an effort to lessen painful symptoms in the rear-
foot. These functional changes in the rearfoot in early
disease have important implications since we were able to
successfully control motion and lessen symptoms by
treating patients with customised foot orthoses [29,30].
However, the patients in the study by Woodburn et al.
2002 had median disease duration of 3 years suggesting
we should attempt to identify rearfoot dysfunction even
earlier and treat accordingly.
One of the limitations of this study is subject selection
bias as these 12 cases were recruited following podiatry
referral and may therefore represent only a subset of early
RA patients with severe foot involvement. The introduc-
tion of Early Arthritis Clinics should permit future access
to a more generalisable population. The sample size was
also too small to permit formal hypothesis testing or sta-
tistical analysis of association between impairment and
biomechanical data. Finally, due to the current limitations
of gait analysis, our biomechanical foot models are insen-
sitive to detection of functional changes at small but
important single joints such as the subtalar, talonavicular,
and lesser toe MTP joints which are involved in the dis-
ease process.BMC Musculoskeletal Disorders 2006, 7:102 http://www.biomedcentral.com/1471-2474/7/102
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Conclusion
In conclusion, in this cohort of RA patients with early dis-
ease we were able to detect moderate to high levels of foot
impairment and associated disability. Furthermore, gait
analysis detected subtle but functionally important
changes to the biomechanical function of the foot. These
findings need to be confirmed in a larger population with
a fuller exploration of the relationship between disease
activity, impairment and function in the foot. This infor-
mation may be useful to distinguish those patients with a
poor prognosis since a therapeutic window of opportu-
nity may also exist for adjunct physical interventions such
as corrective orthoses.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
DET conceived of the study, participated in the design of
the study and carried out the gait analyses.
PSH participated in the design of the study and the coor-
dination of the gait analyses.
PE participated in the design of the study and its coordi-
nation.
JW conceived of the study, participated in the design of
the study, and conducted the gait data analysis and prep-
aration.
All authors read and approved the final manuscript.
Acknowledgements
We would like to acknowledge the support of Mr B Whitham for assisting 
with the gait analysis. Dr. Woodburn's work was supported by a Medical 
Research Council Clinician Scientist Fellowship award.
References
1. Minaker K, Little H: Painful feet in rheumatoid arthritis.  J Can
Med Assoc 1973, 109:724-30.
2. Hulsmans HMJ, Jacobs JWG, van der Heijde DMFM, van Albada-
Kuipers GA, Schenk Y, Bijlsma JWJ: The course of radiologic
damage during the first six years of rheumatoid arthritis.
Arthritis Rheum 2000, 43:1927-40.
3. Ostendorf B, Scherer A, Modder U, Schneider M: Diagnostic value
of magnetic resonance imaging of the forefeet in early rheu-
matoid arthritis when findings on imaging of the metacar-
pophalengeal joints of the hands remain normal.  Arthritis
Rheum 2004, 50:2094-2102.
4. Koski JM: Ultrasound detection of plantar bursitis of the fore-
foot in patients with early rheumatoid arthritis.  J Rheumatol
1998, 25:229-30.
5. Kuper HH, van Leeuwen MA, van Riel PLCM, Prevoo MLL, Houtman
PM, Lolkema WF, van Rijswijk MH: Radiographic damage in large
joints in early rheumatoid arthritis: relationship with radio-
graphic damage in the hands and feet, disease activity, and
physical disability.  Brit J Rheumatol 1997, 38:855-60.
6. Belt EA, Kaarela K, Maenpaa H, Kauppi MJ, Lehtinen JT, Lehto MUK:
Relationship of ankle joint involvement with subtalar
destruction in patients with rheumatoid arthritis. A 20-year
follow-up study.  Joint Bone Spine 2001, 68:154-7.
7. Spiegel TM, Spiegel JS: Rheumatoid arthritis in the foot and
ankle-diagnosis, pathology and treatment.  Foot & Ankle Intl
1982, 6:318-324.
8. Woodburn J, Helliwell PS, Barker S: Three-dimensional kinemat-
ics at the ankle joint complex in rheumatoid arthritis
patients with painful valgus deformity of the rearfoot.  Rheu-
matology 2002, 41:1406-12.
9. Platto MJ, O'Connell PG, Hicks JE, Gerber LH: The relationship of
pain and deformity of the rheumatoid foot to gait and an
index of functional limitation.  J Rheumatol 1991, 18:38-43.
10. Siegel KL, Kepple TM, O'Connell PG, Gerber LH, Stanhope SJ: A
technique to evaluate foot function during the stance phase
of gait.  Foot & Ankle 1995, 16:764-70.
11. O'Connell PG, Siegel KL, Kepple TM, Stanhope SJ, Gerber LH: Fore-
foot deformity, pain, and mobility in rheumatoid and nonar-
thritic subjects.  J Rheumatol 1998, 25:1681-9.
12. Turner DE, Woodburn J, Helliwell PS, Cornwall ME, Emery P: Pes
planovalgus in rheumatoid arthritis: a descriptive and analyt-
ical study of foot function determined by gait analysis.  Musc-
uloskeletal Care 2003, 1:21-33.
13. Woodburn J, Nelson KM, Lohmann Siegel K, Kepple TM, Gerber LH:
Multisegment foot motion during gait: proof of concept in
rheumatoid arthritis.  J Rheumatol 2004, 31:1918-27.
14. Korda J, Balint GP: When to consult the podiatrist.  Best Pract Res
Clin Rheumatol 2004, 18:587-611.
15. Gossec L, Pavy S, Pharm T, Constantin A, Poiraudeau S, Combe B,
Flipo RM, Goupille P, Le Loet X, Mariette X, Puechal X, Wendling D,
Schaeverbeke T, Sibilia J, Tebib J, Cantagrel A, Dougados M: Nonp-
harmacological treatments in early rheumatoid arthritis:
clinical practice guidelines based on published evidence and
expert opinion.  Joint Bone Spine  in press. 2006 Mar 20
16. Helliwell PS, Allen N, Gilworth G, Redmond A, Slade A, Tennant A,
Woodburn J: Development of a foot impact scale for rheuma-
toid arthritis.  Arthritis Rheum 2005, 53:418-22.
17. Carson MC, Harrington ME, Thompson N, O'Connor JJ, Theologis
TN: Kinematic analysis of a multi-segment foot model for
research and clinical applications: a repeatability analysis.  J
Biomech 2001, 34:1299-1307.
18. Combe B, Cantagrel A, Goupille P, Bozonnat MC, Sibilia , Eliauo JF,
Meyer O, Sany J, Dubois A, Daures JP, Dougados M: Predicitve fac-
tors of 5-year health assessment questionnaire disability in
early rheumatoid arthritis.  J Rheumatol 2003, 30:2344-49.
19. Farrow SJ, Khoshaba B, Scott DL, Choy EHS: Foot involvement,
disease activity and disability in rheumatoid arthritis.  Rheu-
matology (Oxford) 2004, 43(suppl 1):140.
20. Hussain SA, Kelly D, Sathi N, George E: Foot function index (FFI):
an assessment of feet related morbidity in patients with
rheumatoid arthritis.  Rheumatology (Oxford) 2003, 42(Suppl
1):127.
21. Tuna H, Birtane M, Tastekin N, Kokino S: Pedobarography and its
relation to radiologic erosion scores in rheumatoid arthritis.
Rheumatol Int 2005, 26:42-7.
22. Turner DE, Davys HJ, Woodburn J: Foot function following fore-
foot reconstruction in rheumatoid arthritis.  Aus J Pod Med
2005, 39:83-9.
23. Davys HJ, Turner DE, Helliwell PS, Conaghan PG, Emery P, Wood-
burn J: Debridement of plantar callosities in rheumatoid
arthritis: a randomized controlled trial.  Rheumatology (Oxford)
2005, 44:207-210.
24. Vidigal E, Jacoby RK, Dixon A, St J, Ratliff AH, Kirkup J: The foot in
chronic arthritis.  Ann Rheum Dis 1975, 34:292-7.
25. Jernberg ET, Simkin P, Kravette M, Lowe P, Gardner G: The poste-
rior tibial tendon and tarsal sinus in rheumatoid flat foot:
magnetic resonance imaging of 40 feet.  J Rheumatol 1999,
26:289-293.
26. Woodburn J, Udupa JK, Hirsch BE, Wakefield RJ, Helliwell PS, Reay
N, O'Connor P, Budgen A, Emery P: The geometrical architec-
ture of the subtalar and midtarsal joints in rheumatoid
arthritis based on MR imaging.  Arthritis Rheum 2002, 46:3168-77.
27. Michelson J, Easley M, Wigley FM, Hellman D: Foot and ankle prob-
lems in rheumatoid arthritis.  Foot & Ankle Intl 1994, 15:608-613.
28. Keenan MAE, Peabody TD, Gronley JK, Perry J: Valgus deformity
of the feet and characteristics of gait in patients who have
rheumatoid arthritis.  J Bone Joint Surg 1991, 73-A:237-247.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Musculoskeletal Disorders 2006, 7:102 http://www.biomedcentral.com/1471-2474/7/102
Page 8 of 8
(page number not for citation purposes)
29. Woodburn J, Helliwell PS, Barker S: A randomized controlled
trial of foot orthoses in rheumatoid arthritis.  J Rheumatol 2002,
29:1377-83.
30. Woodburn J, Helliwell PS, Barker S: Changes in three-dimen-
sional joint kinematics supports the continuous use of foot
orthoses in the management of painful rearfoot deformity in
rheumatoid arthritis.  J Rheumatol 2003, 30:2356-64.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/7/102/pre
pub